• Development Of A Web-Based Quality Of Life Portal For Breast Cancer Patients

    Nov 1, 2015, 00:00

  • The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Topical Filed Treatment Therapies for The Treatment of Actinic Keratosis In Greece

    Nov 1, 2015, 00:00

  • Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients

    Nov 1, 2015, 00:00

  • A Systematic Review of Economic Evaluations in Latin America- Assessing the Factors that affect Adaptation and Transferability of Results

    Nov 1, 2015, 00:00

  • Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study

    Nov 1, 2015, 00:00

  • Willingness to Pay for Innovative Drugs- Anti-Hcv Treatment from the Italian National Health System Perspective

    Nov 1, 2015, 00:00

  • Assesing The Net Fiscal Consequences Of Tobacco Use In A High Consumption And High Tobacco Tax Country- The Case Of Greece

    Nov 1, 2015, 00:00

  • Cost-Minimisation Analysis of Dexmedetomidine Versus Propofol in Mechanical Ventilated Patients at Icu

    Nov 1, 2015, 00:00

  • Pharmacy Information System In Saudi Hospitals- How Far Is It To Meet Pharmacy Benefit Management Program Requierments?

    Nov 1, 2015, 00:00

  • Cross-Sectional Survey Study to Understand Behaviours, Thoughts and Perceptions of Mealtime Insulin Usage In Patients With Type 1 and Type 2 Diabetes

    Nov 1, 2015, 00:00

  • The Economic Burden Of Cardiac Complications Of Percutaneous Coronary Intervention In England- An Analysis Of Hospital Episode Statistics

    Nov 1, 2015, 00:00

  • Trends in Hospital Standardized Mortality Ratios in Japan

    Nov 1, 2015, 00:00

  • Health Utilities Associated with Hypoglycemic Events in Type 2 Diabetes Mellitus (T2DM) Patients Receiving Basal-Bolus Insulin Therapy

    Nov 1, 2015, 00:00

  • Economic Evaluation of Ertapenem in the Treatment of Intra-Abdominal Infections, from the Perspective of Imss

    Nov 1, 2015, 00:00

  • Analysis Of In-Hospital Resource Use After An Ischemic Stroke

    Nov 1, 2015, 00:00

  • Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practi German Base Case

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utility Values In Patients With Migraine

    Nov 1, 2015, 00:00

  • Resource Use and Cost of Chemotherapeutic Treatment for Metastatic Breast Cancer in the Netherlands

    Nov 1, 2015, 00:00

  • The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale

    Nov 1, 2015, 00:00

  • Development Of Medical And Technological Documents On Standardization Of Medical Care In Cardiovascular Diseases In Ukraine

    Nov 1, 2015, 00:00

  • The Evolving Landscape of Early Access Programmes- Comparisons and Implications for Market Access

    Nov 1, 2015, 00:00

  • Healthcare Pathways and Burden of Disease of Patients with Skin and Soft Tissue Infections (Sstis)

    Nov 1, 2015, 00:00

  • High Therapeutic Efficiency With Ledipasvir/Sofosbuvir For The Treatment Of Genotype 1 Chronic Hepatitis C In Portugal

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Respiratory Medication Therapy Adherence Clinic (Rmtac) On Asthma Patients In Malaysia

    Nov 1, 2015, 00:00

  • Quality Of Life And Perspectives Of Happiness In Middle-Aged And Older People With Dysphagia

    Nov 1, 2015, 00:00

  • The International Development of The Modified Hyperphagia Questionnaire

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer

    Nov 1, 2015, 00:00

  • Comparison of Pharmaceutical Pricing and Reimbursement Systems In Turkey And Certain Other Eu Countries

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Bedaquiline for Patients With Multi-Drug Resistant Tuberculosis in South Korea

    Nov 1, 2015, 00:00

  • Costos Unitarios de Servicios Brindados Por Una Unidad de Salud de la Familia- Evidencia en el Caso Paraguayo

    Nov 1, 2015, 00:00

  • Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting

    Nov 1, 2015, 00:00

  • Determinants of Women’s Choice of Place of Intrapartum Care In Uganda- An Analysis of Secondary Data From Udhs

    Nov 1, 2015, 00:00

  • Systematic Review Of Adherence To Oncological Treatments

    Nov 1, 2015, 00:00

  • Economic Burden Outcomes In Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts)

    Nov 1, 2015, 00:00

  • Proposal for A Regulatory Framework for Health Apps to Ensure A Patient Centered Competition Between Providers

    Nov 1, 2015, 00:00

  • The NHS Expenditure Managing Severe Hypoglycemia Episodes in Type 2 Diabetic Patients in Portugal

    Nov 1, 2015, 00:00

  • Associated Factors The Virologic Success In A Group of Patients With Human Immunodeficiency Virus, Managed By A Care Team Integral, Eps|Sura Medellin 2010-2013

    Nov 1, 2015, 00:00

  • Cost Saving Associated With Glucose Meter Accuraccy In Spain

    Nov 1, 2015, 00:00

  • Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder

    Nov 1, 2015, 00:00

  • Generating Costing Algorithms For Oncology Drugs Using Administrative Databases

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Geriatric Diabetics in a Tertiary Care Hospital- A Prospective Study

    Nov 1, 2015, 00:00

  • Developing Bilingual Certificate Programs in Clinical Pharmacy

    Nov 1, 2015, 00:00

  • The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic

    Nov 1, 2015, 00:00

  • Understanding Patients’ Socio-Economic Burden in Rheumatic Diseases

    Nov 1, 2015, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead to Unintended Harm of Ireland’s Health System?

    Nov 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes (Pro) on Market Access Decisions In Markets With Centralized Healthcare Systems

    Nov 1, 2015, 00:00

  • The Use of Single-Arm Evidence In The Comparative Efficacy of Interferon-Free Antivirals for Treatment-Naïve Hepatitis C Genotype 1

    Nov 1, 2015, 00:00

  • Caracterización de Pacientes Con Enfermedad Osteoarticular Desde La Perspectiva Del Aseguramiento en Colombia

    Nov 1, 2015, 00:00

  • Physicians’ Choice As A Comparator In Clinical Trials- Challenges for Pharmacoeconomic Modelling of Innovative Treatments to Support Health Technology Assessments

    Nov 1, 2015, 00:00

  • Outpatient Utilization and Quality Appraisal of Antibiotics in Turkey

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico

    Nov 1, 2015, 00:00

  • Changes In Glucose Lowering Drug Use Before And After A Cancer Diagnosis Among Individuals With Diabetes

    Nov 1, 2015, 00:00

  • Comparação De Custos E Efetividade Entre Ml- Flow E Baciloscopia Para Auxílio Diagn”Stico E Tratamento Da Hanseníase

    Nov 1, 2015, 00:00

  • Risk Of Pneumonia Associated With The Use Of Ics/Laba- A Retrospective Cohort Study In Korea

    Nov 1, 2015, 00:00

  • Costo-Efectividad Del Desfibrilador Externo Automático (Dea) Comparado Con Reanimación Cardiopulmonar Básica (Rcp) En Colombia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Tenecteplase In The Treatment of Acute Myocardial Infarction In Mexico

    Nov 1, 2015, 00:00

  • Reducing The Barriers To Capturing Patient Reported Outcomes In Oncology Studies

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service

    Nov 1, 2015, 00:00

  • Biosimilars- Accessing the Uk Market

    Nov 1, 2015, 00:00

  • Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression- An Application To Combination Therapies In Hiv

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of A Genomic Test Compared To Standard Of Care In Breast Cancer Patients In France

    Nov 1, 2015, 00:00

  • A Literature Review To Evaluate The Pharmacoeconomic Value Of Ranolazine For The Treatment Of Symptomatic Chronic Stable Angina

    Nov 1, 2015, 00:00

  • A Decision Options Approach to Antibiotic RD Investment

    Nov 1, 2015, 00:00

  • The Effect of Positioning The Lower Extremities on Postoperative Bleeding After Total Knee Replacement

    Nov 1, 2015, 00:00

  • Measuring Post-Partum Hemorrhage In Low-Resource Settings- The Diagnostic Validity Of Weighted Blood Loss Versus Quantitative Changes In Hemoglobin

    Nov 1, 2015, 00:00

  • Modeling The Burden of Abdominal Aortic Aneurysm (Aaa) In Europe In 2013

    Nov 1, 2015, 00:00

  • condition Specific Utilities- Impact on Icer in a Markov Model for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Cost Comparison of Oral Versus iv Vinorlbine in France in Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service

    Nov 1, 2015, 00:00

  • Health State Utilities Associated With Glucose Monitoring Devices

    Nov 1, 2015, 00:00

  • Prevalence Of Chronic Kidney Disease In India- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • The Use of Real World Data to Build Economic Models- A Case Study of Osteoporosis

    Nov 1, 2015, 00:00

  • The Relationship Between Socioeconomic Characteristics And Self-Rated Health In Greece

    Nov 1, 2015, 00:00

  • Biossimilars, Are they Really Cost Saving? The Case of Recombinant Human Follicle Stimulating Hormone in Portugal

    Nov 1, 2015, 00:00

  • Steering vaccines through the uk system - what factors influence the likelihood of positive and negative recommendations?

    Nov 1, 2015, 00:00

  • Uso de recursos y costos relacionados al tratamiento de complicaciones de la diabetes mellitus tipo 2 (dmt2) en colombia. Una estimacion basada en guias de practica clinica (gpc)

    Nov 1, 2015, 00:00

  • To Study The Clinical Characteristics, Treatment Pattern And Factors Associated With The Total Hospital Cost In Acute Respiratory Distress Syndrome In Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Decrease of Patient Costs in the Netherlands- a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc)

    Nov 1, 2015, 00:00

  • Insurance Plan Switch Patterns Among Breast Cancer Patients Compared to Non-Cancer Patients

    Nov 1, 2015, 00:00

  • Cost and Cost-Effectiveness Data on Pancreatic Cancer- a Comprehensive Review of the Literature

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Umeclidinium/Vilanterol In Symptomatic Copd Spanish Patients

    Nov 1, 2015, 00:00

  • Mental Health Disorder Prevalence Trends In Germany- A Longitudinal Analysis

    Nov 1, 2015, 00:00

  • Reference Pricing For Laboratory Tests In The United States- Impact On Prices And Spending

    Nov 1, 2015, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates for Chronic Hcv Gt1 Drugs in Poland

    Nov 1, 2015, 00:00

  • Machine Learning For Identifying Potentially Undiagnosed Post-Stroke Spasticity Patients In United Kingdom

    Nov 1, 2015, 00:00

  • Can Advances in Health Monitors Lead to Health Being Looked at as A Commodity?

    Nov 1, 2015, 00:00

  • Mortality In A University Pediatric Hospital In Colombia 2000 – 2014

    Nov 1, 2015, 00:00

  • Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China

    Nov 1, 2015, 00:00

  • Comparative Efficacy And Costs Of Treatment Sequences In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Meta-Analysis to Support Technology Submissions to Health Technology Assessment Authorities- Criticisms By Nice And Evidence Review Groups in the Uk

    Nov 1, 2015, 00:00

  • French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours- Perspective For Future Trends

    Nov 1, 2015, 00:00

  • International Differences in the Role of Payer and Administrative Controls in Prescribing Decisions

    Nov 1, 2015, 00:00

  • Relationship Between Non Compliance to Claim Medication in Pharmacy and Incidence of Hospitalizations in Patients with Breast Cancer

    Nov 1, 2015, 00:00

  • Using Machine Learning Techniques To Classify Oecd Countries According to Health Expenditures

    Nov 1, 2015, 00:00

  • Survival And Cost Among Photodynamic Therapy Patients With Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • The Role of Education In The Management of Type 1 Diabetes Mellitus In England

    Nov 1, 2015, 00:00

  • Longitudinal Changes in Medical Services Costs from 2006 to 2012 for Newly Diagnosed T2D Patients

    Nov 1, 2015, 00:00

  • Using Real-World Hospital Purchasing And Consumption Data To Improve Healthcare Systems Efficiencies

    Nov 1, 2015, 00:00

  • Cytogenetics And Dopamine Receptor (Drd2) Gene Polymorphism In Schizophrenia Patients

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Long-Acting Insulin Analogues in the Perspective of Brazilian Public Health System

    Nov 1, 2015, 00:00

  • Preference Elicitation On Benefits And Risks Of Medicines Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

    Nov 1, 2015, 00:00

  • Medical Care And Costs of Patients With Systemic Lupus Erythematosus In Taiwan

    Nov 1, 2015, 00:00

  • Economic Benefits Of Endometrial Radiofrequency Ablation Compared With Other Endometrial Ablation Techniques In Women With Menorrhagia- A Retrospective Analysis With German Health Claims Data

    Nov 1, 2015, 00:00

  • Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use- Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)

    Nov 1, 2015, 00:00

  • Healthcare Pathways And Burden of Disease of Patients With Inflammatory Bowel Diseases (Ibd)

    Nov 1, 2015, 00:00

  • Long-Term Cost-Effectiveness of Transanal Irrigation In Patients With Neurogenic Bowel Dysfunction Who Have Failed Standard Bowel Care

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Treatment Patients With Craniocerebral Injury In Ukraine

    Nov 1, 2015, 00:00

  • Usability Testing of an Integrated Glucometer and Handheld Electronic Patient-Reported Outcome System

    Nov 1, 2015, 00:00

  • Accessing The Medical Devices Market In Egypt And Saudi Arabia- A Systematic Review Of Policies And Regulations

    Nov 1, 2015, 00:00

  • Effects Of Lifestyle Interventions On Body Mass Index In Breast Cancer Patients

    Nov 1, 2015, 00:00

  • Implant Versus Oral Contraception Use- 3-Years Budget Impact Analysis for the National Heal System in Portugal

    Nov 1, 2015, 00:00

  • The Association Between Tolerability Issues and Health Outcomes Among Patients with Hcv in Brazil

    Nov 1, 2015, 00:00

  • Proton Pump Inhibitors In Italy- It’s Time to Make A (Policy) Change

    Nov 1, 2015, 00:00

  • New Copd Medicinal Products Entrance Analysis And Their Influence On The Number And Cost Of Hospitalizatons Due To Copd Exacerbations

    Nov 1, 2015, 00:00

  • Association Between Depression And Discontinuation With Antidiabetic Drugs

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting

    Nov 1, 2015, 00:00

  • Conflicts’ Mediation Between Consumers and Health Plans- The Usage Profile of The Available Channels for Complaints

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

    Nov 1, 2015, 00:00

  • Safety And Insurance Premium Implications For Hospitals Based On Subcutaneous Versus Intravenous Administration Of Oncology / Hematology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • Medication Adherance and Satisfaction With Treatment In Patients With Diabetes Mellitus Receiving Oral Combination Therapy- Data of A Real-World Study

    Nov 1, 2015, 00:00

  • Does use of calcium channel blockers affect the risk of incident active tuberculosis disease? A nested case control study on a national health claim database

    Nov 1, 2015, 00:00

  • Burden Of Symptomatic Copd Patients In Spain- Data From Continuing To Confront Copd International Patient Survey 2012-2013

    Nov 1, 2015, 00:00

  • Systematic Review And Meta-Analysis of Efficacy And Safety of Simeprevir And Sofosbuvir For Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00

  • Economic Evaluation For The Rapid Test Dpp® Hiv-Syphilis Assay With Immunochromatography In Pregnant Women In Mexico

    Nov 1, 2015, 00:00

  • The Epipen4schools® Survey- Staff Training And Use Of Epinephrine Auto-Injectors For The Treatment Of Anaphylaxis In Large Us School Districts

    Nov 1, 2015, 00:00

  • Role Of Budget Impact Analysis In Market Access Of Biosimilars

    Nov 1, 2015, 00:00

  • A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis- Compliant Vs. Non-Compliant Patients

    Nov 1, 2015, 00:00

  • The Research on The Relationship Between The Ovarian Function Damage With Fluorosis and The Protective Effect of Selenium

    Nov 1, 2015, 00:00

  • Vedolizumab In Crohn’s Disease; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00

  • Delay Of Optimal Nocturia Treatment Is Costly- Results Of A Real World Survey Of Patients In Europe And The Usa

    Nov 1, 2015, 00:00

  • Search for Clinically and Economically Effective Lymphomas Treatment

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Rivaroxabán Como Profilaxis En Cirugía De Reemplazo Total De Cadera Y/O De Rodilla Frente A Enoxaparina, En Colombia

    Nov 1, 2015, 00:00

  • Resource And Cost Savings Due To Subcutaneous Versus Intravenous Administration Of Oncology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Utilidad Del Uso De Cetuximab Como Última Línea De Tratamiento Del Cáncer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • Analysis of The Cost of Invasive Fungal Infections In Patients With Hemopoetic Stem Cell Transplantation

    Nov 1, 2015, 00:00

  • Cost utility analysis of spinal cord stimulation vs. Reoperation in the treatment of failed back surgery syndrome in colombia

    Nov 1, 2015, 00:00

  • Increased Costs Due To Myocardial Infarction (Mi) In Fran An Observational Analysis Using A Claims Database

    Nov 1, 2015, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary In Case Of Erythropoietin Products

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated With Non-Valvular Atrial Fibrillation In Italy

    Nov 1, 2015, 00:00

  • Decision Drivers in Health Technology Assessment in Hepatitis C

    Nov 1, 2015, 00:00

  • The german nice or the german nasty? an analysis of iqwig decisions and requirements for an ‘added benefit'

    Nov 1, 2015, 00:00

  • Costs of Relapse of Schizophrenia for Colombian Health System

    Nov 1, 2015, 00:00

  • The Most Profitable Health Insurance “Company” In Turkey

    Nov 1, 2015, 00:00

  • Regulations of The German Drug Market

    Nov 1, 2015, 00:00

  • La Canasta Basica de Medicamentos Como Estrategia Para Mejorar el Acceso y Costo de Los Medicamentos en Panama

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson’S Disease

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 4 Pro Questionnaires for Uterine Fibroids

    Nov 1, 2015, 00:00

  • Inflation, Inflexibility and Irrelevance – the Need for Inflation to be Accounted for in Icer Thresholds

    Nov 1, 2015, 00:00

  • Current Challenges and Opportunities to Market Access in Brazil, Argentina, Mexico and Colombia

    Nov 1, 2015, 00:00

  • Resource Utilization And Treatment Costs Of Stroke In Patients With Non-Valvular Atrial Fibrillation In Spain

    Nov 1, 2015, 00:00

  • Medical Devices For Bandaging And Plasters. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Comparison of Cost of Treatment of Selected Cancers with Patented Drugs- India Versus its Neighbors

    Nov 1, 2015, 00:00

  • The Indirect Costs of Types 1 Diabetes Mellitus Associated with Absenteeism in Poland in 2013

    Nov 1, 2015, 00:00

  • Review Of The Current Status Of Ras Mutation Testing In Patients With Metastatic Colorectal Cancer (Mcrc)- Flash-Ras Study

    Nov 1, 2015, 00:00

  • Sq® Hdm Slit-Tablets In Addition To Pharmacotherapy Are Cost-Effective Compared To Pharmacotherapy Only In Treating Patients With Allergic Asthma

    Nov 1, 2015, 00:00

  • Ankylosing Spondylitis Treatment and Follow-Up Costs in Colombia

    Nov 1, 2015, 00:00

  • Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    Nov 1, 2015, 00:00

  • Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model

    Nov 1, 2015, 00:00

  • Tioropium+Olodaterol Respimat; Budget Impact In The Uk

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Cetuximab In First-Line Treatment Of Patients With Metastatic Colorectal Cancer In Belgium And The Netherlands

    Nov 1, 2015, 00:00

  • Which Risk Share Agreements are Available and are Those Applied In Global Reimbursement Decisions?

    Nov 1, 2015, 00:00

  • Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain- A Delphi Study

    Nov 1, 2015, 00:00

  • The Impact of Anti-Tnf (Etanercept) Therapy on Work Productivity in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in the Czech Republic

    Nov 1, 2015, 00:00

  • Risk Factors and Causes of Intrauterine Death

    Nov 1, 2015, 00:00

  • Impacto Orçamentário do Everolimo e Sirolimo para Imunossupressão em Transplantados Hepáticos no Sistema Público de Saúde do Brasil

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Access to Biologics for Rheumatoid Arthritis in the Public Sector of a Latam Country

    Nov 1, 2015, 00:00

  • There Is Evidence of Increased Risk of Cancer In Patients Using Human Insulin Analogue Glargine For Treatment of Diabetes Mellitus - Overview Based Evaluation

    Nov 1, 2015, 00:00

  • Network Meta-Analysis for Health Technology Submissions Worldwide- A Report Checklist for Network Meta Analysis Best Practices Globally

    Nov 1, 2015, 00:00

  • Management Of Sore Throat In Community Pharmacy In Fran A National Observational Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18 Month Booster Dose of A Pertussis-Containing Vaccine on The Australian National Immunisation Program- A Dynamic Model-Based Analysis

    Nov 1, 2015, 00:00

  • Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Ferric Carboxymaltose in Patients with Colon Cancer and Anemia

    Nov 1, 2015, 00:00

  • Indirect Treatment Comparison (Itc) To Demonstrate The Utility Of Oncolitbank- An Oncology Literature Registry

    Nov 1, 2015, 00:00

  • The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Insulin Analogues Compared with Multiple Daily Injections of Human Insulin for the Treatment of 15 Years Old or Older Patients with Type 1 Diabetes Mellitus in Colombia

    Nov 1, 2015, 00:00

  • Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers- Patterns of Treatment and Costs

    Nov 1, 2015, 00:00

  • Representing the Threshold in the Cost-Effectiveness Plane- Proposing a New Graphical Convention

    Nov 1, 2015, 00:00

  • Network Meta-Analysis On Prevention Of Stroke For Patent Foramen Ovale Closure

    Nov 1, 2015, 00:00

  • Differences And Similarities In Hta- A Comparative Analysis Of The Decision-Making Processes For Cancer Drugs Across 4 Countries

    Nov 1, 2015, 00:00

  • Productivity Loss Costs Attributable to Obesity in Working Patients with Diabetes in the US

    Nov 1, 2015, 00:00

  • Tratamiento Ambulatorio Versus Hospitalario Relacionado A Agudizaciones En Pacientes Con Asma Desde Una Perspectiva Institucional Publica Mexicana

    Nov 1, 2015, 00:00

  • Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • National Estimates of Prevalence and Patterns of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease in Nursing Home and Home Healthcare Settings in the United States

    Nov 1, 2015, 00:00

  • Does Out-Patient Medical Insurance Policy Work Among Ckd Patients In Non-Dialysis Phases? Evidence From Two Sample Cities In China

    Nov 1, 2015, 00:00

  • An Evaluation of a New Regional Decision making Process in Sweden for High-Cost Hospital Therapies

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Del Uso De Sorafenib En Pacientes Con Carcinoma Hepatocelular En Estadios Avanzados, Para El Contexto Ecuatoriano

    Nov 1, 2015, 00:00

  • The End of the Exceptional Financing of Erythropoiesis-Stimulating Agents in French Hospitals- What are the Impacts For Public Hospitals of Paris ?

    Nov 1, 2015, 00:00

  • Characterization of Osteoporosis In Portugal - Treatment Patterns And Reasons for Under-Treatment and Non-Persistence With Pharmacological Treatments

    Nov 1, 2015, 00:00

  • Antipsychotic Exposure And Risk of Stroke- A Systematic Review And Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • Systematic Literature Review And Critical Appraisal Of The Suitability Of The Outcome Measures Used In The Idiopathic Pulmonary Fibrosis

    Nov 1, 2015, 00:00

  • Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

    Nov 1, 2015, 00:00

  • An Open Label, One Arm Study To Evaluate The Efficacy And Safety of Cerebrolysin In Patients With Acute Severe Ischemic Stroke In Mexico

    Nov 1, 2015, 00:00

  • Finding The Optimal Screening Program For Unknown Atrial Fibrillation Using Simulation Models

    Nov 1, 2015, 00:00

  • Systematic Review Of Productivity Losses Associated With Cardiovascular Disease In Europe

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Chemotherapy Regimen In Metastatic Breast Cancer Egyption Prospective

    Nov 1, 2015, 00:00

  • Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

    Nov 1, 2015, 00:00

  • Prevalence of Self-Medication and Its Reason Among Pharmacy Students in India- A cross-sectional study

    Nov 1, 2015, 00:00

  • Societal and Non-Healthcare Costs Associated With Atypical Haemolytic Uraemic Syndrome In The Uk- Results of A Patient Survey

    Nov 1, 2015, 00:00

  • Aumento del Riesgo de Cancer por Efecto de Variaciones Acumuladas en la Exposici”n a la Radiacion en Estudios de Radiología Convencional y Tomografía Computarizada en Pacientes Pediátricos

    Nov 1, 2015, 00:00

  • Análise De Custo-Utilidade Em Pacientes Com Insuficiência Renal Crônica Submetidos À Terapia Renal Substitutiva (Trs)

    Nov 1, 2015, 00:00

  • Contraception Patterns In Fran A Real-World Database Analysis

    Nov 1, 2015, 00:00

  • Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events- a Large United States Real World Study

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Bladder Cancer- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Evaluaci”N De Costo-Efectividad De La Implementaci”N De Monitoreo Ambulatorio De Presi”N Arterial Versus Perfil De Presi”N Arterial Para El Diagn”Stico De Hipertensi”N En El Sistema Público Chileno

    Nov 1, 2015, 00:00

  • Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level

    Nov 1, 2015, 00:00

  • The Impact Of Pharmaceutical Innovation On Longevity In Portugal, 2002–2010

    Nov 1, 2015, 00:00

  • Economic and Humanistic Burden of Ductal Carcinoma in Situ

    Nov 1, 2015, 00:00

  • Construction Of Simulation Techniques For Development Of Optimal Cervical Cancer Screening Strategies- Experience Of Ukraine

    Nov 1, 2015, 00:00

  • A Pitcure of Private Health Insurance Policyholders in Italy

    Nov 1, 2015, 00:00

  • The Analysis of Telemedicine Technologies In Pediatric Patients

    Nov 1, 2015, 00:00

  • Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Bra A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies

    Nov 1, 2015, 00:00

  • Migration of the Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmstm) from Paper to an Electronic Diary Format

    Nov 1, 2015, 00:00

  • Association between Weight Change, Diabetes-Related Healthcare Costs, and HbA1c among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Barriers To Participation In Trials Of Cancer- A Survey On Clinical Research Perception

    Nov 1, 2015, 00:00

  • Determinant Factors of the Administrative Pathway to Access Medicines in the Brazilian Health System

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Neoplasm of Colon

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Kidney Cancer In Slovakia

    Nov 1, 2015, 00:00

  • Prices of Pharmaceuticals Under a Generic Price Linkage System And a Reference Price System- Comparison of Austria and Finland

    Nov 1, 2015, 00:00

  • Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy

    Nov 1, 2015, 00:00

  • Reduction of Complications and Associated Costs for Type 2 Diabetic Patients Using Continuous Subcutaneous Insulin Infusion In The Uk

    Nov 1, 2015, 00:00

  • Patient Reported Outcome in Health Services Research- A Prospective Study of Orthopedic Surgery in Routine Care in Switzerland

    Nov 1, 2015, 00:00

  • Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure- 1 Year Follow-Up from the Brazilian Public Healthcare System Database

    Nov 1, 2015, 00:00

  • Utilizacion De Antibacterianos De Uso Restringido En Pacientes Adultos Hospitalizados En El Hospital Las Higueras - Talcahuano

    Nov 1, 2015, 00:00

  • A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials

    Nov 1, 2015, 00:00

  • Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries

    Nov 1, 2015, 00:00

  • Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China

    Nov 1, 2015, 00:00

  • Cost Implications of Further Limiting or Increasing Generic Prescribing of Antiepileptics In English And Welsh General Practices

    Nov 1, 2015, 00:00

  • Assessing the Translatability of the Term “Distressed”

    Nov 1, 2015, 00:00

  • Building a Bridge Between Clinical Evidence Research and Patient Preference Research

    Nov 1, 2015, 00:00

  • Estimating Lifetime Medical Costs From Censored Claims Data

    Nov 1, 2015, 00:00

  • Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

    Nov 1, 2015, 00:00

  • Descriptive Epidemiology And Treatment Strategies Used In Multiply Myeloma In The Slovak Republic. Results From The Cross-Sectional Survey In The Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Orphan Drugs Assessment in Germany- A Comparison with Other International HTA Agencies

    Nov 1, 2015, 00:00

  • Patient Reported Outcomes in the Development of new Medications for Type 2 Diabetes- a Review of Recently Approved Products

    Nov 1, 2015, 00:00

  • Cost-Utility Of Ranolazine For The Symptomatic Treatment Of Patients With Chronic Angina Pectoris In Greece

    Nov 1, 2015, 00:00

  • Modelling The Likely Impact of The Obesity Epidemic on Mortality And Cause of Death In Older Adults

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey- An Expert Panel Approach For Estimation of Costs

    Nov 1, 2015, 00:00

  • Development of A Precis-2 Scoring Grid- How Pragmatic are Pragmatic Trials of Surgical and Pharmaceutical Interventions?

    Nov 1, 2015, 00:00

  • Cost Analysis of Proton Pump Inhibitors In The Treatment of Gastroesophageal Reflux Disease In Ukraine

    Nov 1, 2015, 00:00

  • Increase Arv Access for Plwha In Dominican Republic Through The Transition From Vertical Supply System to An Integrated National Pharmaceutical System

    Nov 1, 2015, 00:00

  • Measurement Of Hope In Patients With Cancer

    Nov 1, 2015, 00:00

  • Assessment of Hiv-Related Quality of Life in a Representative Sample Of French Patients using Multivariate Multi-Block Statistical Models

    Nov 1, 2015, 00:00

  • Economic Impact of Expanded Use of Biologic Therapy for Crohn’s Disease In Latin American Countries

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device

    Nov 1, 2015, 00:00

  • A Systematic Review Of Markov Models Evaluating Multi-Component Disease Management Programs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management

    Nov 1, 2015, 00:00

  • Impact of Hta – an Irish Case Study

    Nov 1, 2015, 00:00

  • Progressive Disease Does Not Impact Hrqol In Patients Receiving Nivolumab For The Treatment Of Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Impacto Orçamentário Do Everolimo, Sirolimo E Tacrolimo Para Imunossupressão Em Transplantados Cardíacos No Sistema Público De Saúde Do Brasil

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Impact Of Percutaneous Coronary Interventions On The Hospitalization Cost, Length Of Stay And Mortality Of Patients Hospitalized With Acute Coronary Syndromes

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de Un Paquete de Tres Torundas de Algodón Estériles Frente a Toallas Impregnadas Con Solución Antiséptica Como Estrategia de Antisepsia en Venopunción

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden

    Nov 1, 2015, 00:00

  • Targeted Combination Regimes In Oncology Challenges for Pricing and Reimbursment In Switzerland- Analysis of The Implication and Operational Requirement For Implementation of An Indication Code

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of the Introduction of Routine Varicella Vaccination in Children in the United Kingdom

    Nov 1, 2015, 00:00

  • Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)

    Nov 1, 2015, 00:00

  • Medical Costs And Resources Consumption In Patients With Atrial Fibrillation- An Italian Observational Study

    Nov 1, 2015, 00:00

  • Pro Self-Assessment and Patient Retention in Major Depression Studies- Efficiency of a Direct-To-Patient Contact Approach

    Nov 1, 2015, 00:00

  • Pattern And Factors Associated With Readmission In Patients Hospitalized For Chronic Obstructive Pulmonary Disease In Taiwan

    Nov 1, 2015, 00:00

  • A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium

    Nov 1, 2015, 00:00

  • Cognitive Symptoms In Major Depressive Disorder And Their Italian Psychiatrists’ Perception

    Nov 1, 2015, 00:00

  • Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

    Nov 1, 2015, 00:00

  • Uptake Of Filgrastim ‘Biosimilars’ In The United States- Analysis Of A Medical Transcription Database Of Patient Office Visits

    Nov 1, 2015, 00:00

  • Patients Experience At Hospital Discharge and Readmissions

    Nov 1, 2015, 00:00

  • Using Decision Making Clinical Scenarios to Appraise Preferences and Value Judgments in Health Technology Assessment (Hta)

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • Examination of Water Consumption- Knowledge About Water Consumption In Population of Bátya And Pécs

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Cardio-Desfibrilador Implantable Comparado Con La Terapia Farmacológica Optima Para El Tratamiento De Los Pacientes Con Falla Cardiaca En Colombia

    Nov 1, 2015, 00:00

  • Son útiles los enfoques de separación de funciones y cadena de valor para mejorar la organización, regulación y acceso a medicamentos?

    Nov 1, 2015, 00:00

  • Selecting Evidence-Based Preventive Treatment Thresholds By Optimizing Preferred Outcomes

    Nov 1, 2015, 00:00

  • The Economic Burden of Brain Disorders In Korea

    Nov 1, 2015, 00:00

  • Are Qalys An Appropriate Measure To Use When Evaluating Public Health Interventions In The Uk?

    Nov 1, 2015, 00:00

  • Access to Healthcare Among International Immigrants in Chile- Repeated Cross-Sectional Analysis of Casen Survey 2006-2009-2011

    Nov 1, 2015, 00:00

  • Envolvimento do Público no Processo de Incorporação de Tecnologias no Sus

    Nov 1, 2015, 00:00

  • A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia

    Nov 1, 2015, 00:00

  • Practices of Substance Abuse and Risky Sexual Behavior Among Adama Science and Technology University Undergraduate Students in 2012/13 Academic Years

    Nov 1, 2015, 00:00

  • Predictors of 10-Year Mortality After Primary Femoral Neck Fracture In Elderly Patients

    Nov 1, 2015, 00:00

  • The Economics of the Treatment and Follow-Up of Patients with Glioblastoma

    Nov 1, 2015, 00:00

  • Immunisation in Latin America- Factors Preventing Uptake of Cost-Effective Vaccines

    Nov 1, 2015, 00:00

  • First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d

    Nov 1, 2015, 00:00

  • The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom- Results From The Pgrx-3 Real World Dataset

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Adrenal Insufficiency Receiving Plenadren Compared With Immediate-Release Hydrocortisone

    Nov 1, 2015, 00:00

  • Statin Use and Risk of New-Onset Type 2 Diabetes Mellitus and Cardiovascular Disease- a Nationwide Population-Based Observational Study Using National Claim Data

    Nov 1, 2015, 00:00

  • The Rheumatologist’s Perspective In Diagnostic Course and Management of Familial Mediterranean Fever

    Nov 1, 2015, 00:00

  • Reimbursement of Orphan and Expensive Drugs In The Netherlands- Exploration of Essential Criteria In The Decision Making Process

    Nov 1, 2015, 00:00

  • Additional Cost of Vte In Patients with Cancer- an Approach Based Databases

    Nov 1, 2015, 00:00

  • Cost-Effectivness Analysis of Shizophrenia Treatment With Haloperidol , Olanzapine And Risperidone In Bosnia and Hercegovina ,Republic of Srpska By Application of The Markov Model

    Nov 1, 2015, 00:00

  • An Analysis Of Drivers Of Positive And Negative Appraisals By Nice’s Medical Technology Evaluation Programme (Mtep)

    Nov 1, 2015, 00:00

  • Using Incentives to Improve Health-Related Behaviours- A Review of Incentive-Based Trials

    Nov 1, 2015, 00:00

  • Prediction Of Future Health Insurance Expenditures In Hungary According To Population Forecast Scenarios

    Nov 1, 2015, 00:00

  • Drug Pricing Information Management- Development Of A Web Based E-Pricing System

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Trastuzumab-Emtansine Para El Manejo De Pacientes Con Cáncer De Mama Her2 Positivo Avanzado Con Tratamiento Previo Con Trastuzumab Y Un Taxano Por Separado O En Combinación, Para Venezuela

    Nov 1, 2015, 00:00

  • Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd)- are Current Models Suitable to Evaluate Personalized Medicine

    Nov 1, 2015, 00:00

  • The Challenges in Evaluating the Cost-Effectiveness of Complex Interventions

    Nov 1, 2015, 00:00

  • Public Health Outcomes of Paediatric Influenza Vaccination With An Intranasal Tetravalent Live Attenuated Vaccine In Belgium Using A Dynamic Transmission Model

    Nov 1, 2015, 00:00

  • Análisis Del Comportamiento De La Drepanocitosis En Colombia, Desde La Perspectiva Del Uso De Servicios De Salud

    Nov 1, 2015, 00:00

  • Current Perception of Upcoming Cost-Effectiveness Requirements in Japan- a Survey on the Perspective of Pharmaceutical Industry

    Nov 1, 2015, 00:00

  • Health Technology Assessment In Chronic Hepatitis C- Assessment of Decision Landscape And Manufacturer Inputs In Six Agencies

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Gefitinib In The Treatment Of Non-Small Cell Lung Cancer In China

    Nov 1, 2015, 00:00

  • Streamlining The Access Decision Process For German Patients to Receive Reimbursed Treatments In Another European Union Member State

    Nov 1, 2015, 00:00

  • Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain

    Nov 1, 2015, 00:00

  • Evaluation of Psoriasis Patients’ Attitude to Risk- Benefit And Therapeutic Tradeoffs In Their Choice of Treatments

    Nov 1, 2015, 00:00

  • Relationship between Spending on Diabetes Drugs and Occurrence of Risks Associated with Type 2 Diabetes in English General Practices

    Nov 1, 2015, 00:00

  • Work Capacity And Health Status Test of Police Officers

    Nov 1, 2015, 00:00

  • Promis® Physical Function Multilingual Translations- Progress And Outlook

    Nov 1, 2015, 00:00

  • Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

    Nov 1, 2015, 00:00

  • Risk Factors for Coronary Artery Disease In Patients With Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Economic Evaluations of Treatments for Inflammatory Bowel Diseases

    Nov 1, 2015, 00:00

  • Recent Update to Russia’s Essential Drugs List and Seven Nosologies- Clinical Differentiation And Local Manufacturing Implications for New Drug Inclusion

    Nov 1, 2015, 00:00

  • Trends In End-Of-Life Appraisals And Recommendations By Nice For Oncology Therapies

    Nov 1, 2015, 00:00

  • Total Annual Cost Associated with Best Supportive Care of Patients with Unresectable Advanced Non-Small-Cell Lung Cancer Under Real-World-Conditions in Relation to Results of International Studies

    Nov 1, 2015, 00:00

  • Pharmacoeconomical Characteristics of Different Strategies of Hemostasis During Extensive Hepatectomy

    Nov 1, 2015, 00:00

  • Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies- A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...

    Nov 1, 2015, 00:00

  • Risk of Fracture in Type 2 Diabetes Mellitus Patients- Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

    Nov 1, 2015, 00:00

  • Clinical and Economic Impact of Chronic Heart Failure in General Practi Analysis of 13.633 Patients

    Nov 1, 2015, 00:00

  • The Consequences Of Replacing The Fleischner Guidelines By A Software-Based Volume Doubling Time Technique- An Early-Stage Research

    Nov 1, 2015, 00:00

  • Cost of Paediatric Vaccine Administration in the United Kingdom (UK)- a Time and Motion (TM) Study

    Nov 1, 2015, 00:00

  • Over-Prescription Of Fingolimod In Germany

    Nov 1, 2015, 00:00

  • Irrational Drug Use Pattern In Hospitals. A Warning for Health Care System

    Nov 1, 2015, 00:00

  • The Competition Between Drugstore And Primary Care And Treatment Choice Of Patients In The Context Of Essential Medicine Policy In Rural China

    Nov 1, 2015, 00:00

  • The 3-Arm Strategy for Readmission Prevention- Automated Predictive Modeling, Readmission Prevention Intervention, and Monitoring

    Nov 1, 2015, 00:00

  • Disease Prevalence and Healthcare Resources Consumption in Patients with Basal Cell Carcinoma in Italian Lhus

    Nov 1, 2015, 00:00

  • Evaluation of The Effect of Crude Leaves Extract of Indigofera Spicata Forssk.(Fabaceae) on Blood Glucose Level of Normoglycemic, Oral Glucose Loaded and Alloxan Induced Diabetic Rodents

    Nov 1, 2015, 00:00

  • Analysis Of Costs For Diagnosis And Differential Diagnosis Of Patients With Possible Temporomandibular Disorders In Ukrane

    Nov 1, 2015, 00:00

  • Burden of Heart Failure In Latin America- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada

    Nov 1, 2015, 00:00

  • Evaluation of Inpatients’satisfaction in Pafos General Hospital, Cyprus

    Nov 1, 2015, 00:00

  • Effect of Educational Intervention on Osteoporosis Knowledge Among University Female Students in Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Efficacy And Safety Profile Of Combined Targeted Therapy Against Egfr And Vegf In Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Inpatient Burden Among Patients With Cystic Fibrosis Who Are Homozygous for The F508del Mutation

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy

    Nov 1, 2015, 00:00

  • Prescription Patterns Of Drugs For Attention-Deficit/Hyperactivity Disorders In Japanese Children And Adolescents

    Nov 1, 2015, 00:00

  • The Influence Of The Revision Of The Medical Fee Schedule On National Hospital Organisation Hospitals In Japan

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference and Microvascular Complications in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • Economic Burden and Quality of Life of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Plaque Psoriasis In The Italian Setting

    Nov 1, 2015, 00:00

  • Burden of Disease of Ovarian Cancer in Spain. Ovarcost Study

    Nov 1, 2015, 00:00

  • Reducing Insulin Syringe Reuse Can Help Lower Cost of Insulin Waste In Brazil

    Nov 1, 2015, 00:00

  • How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico

    Nov 1, 2015, 00:00

  • Intra- And Extra-Organizational Factors Affecting Community Pharmacy Performance

    Nov 1, 2015, 00:00

  • Global Publication Trends in Medical Nutrition Health Economics

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Blood Clotting Factor Concentrates In The Treatment of Von Willebrand Disease

    Nov 1, 2015, 00:00

  • Comparative Tolerability of New Antipsychotic Drugs in Schizophrenia- A Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease

    Nov 1, 2015, 00:00

  • From Phase Ii Studies to Hta Submissions- Optimal Use of Evidence for Informed Decisions

    Nov 1, 2015, 00:00

  • Costs Of Compression Therapy In Venous Leg Ulcers In Germany And Modelling Of The Economic Effects Of Regional Disparities In Health Care

    Nov 1, 2015, 00:00

  • A Discrete Choice Experiment For Engaging Patients In Reimbursement Decision Making- Patient Preferences On Adjuvant Chemotherapy In Breast Cancer

    Nov 1, 2015, 00:00

  • Quantifying The Impact of Treatment on The Public Health Burden of Adpkd- A Uk Case Study Using The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • Monitoring Of Critical Laboratory Results To Improve Quality Of Patient Care In A Large Urban Clinic In Uganda

    Nov 1, 2015, 00:00

  • Students’ Knowledge and Perceptions Towards Quality Use of Medicines- A Descriptive Analysis From Universiti Sains Malaysia

    Nov 1, 2015, 00:00

  • An Update on Healthcare Resource Use and Economic Burden In Alzheimer’s Disease In The United States (Us) From A Medicare Sample Analysis

    Nov 1, 2015, 00:00

  • Economic Analysis of Outpatient Parenteral Antimicrobial Therapy (Opat)- A Systematic Review

    Nov 1, 2015, 00:00

  • A Retrospective, Cross Sectional Study on the Prevalence of Hypertension and Treatment Status in Obese Patients Using a Healthcare Database in Japan

    Nov 1, 2015, 00:00

  • Biologics In Ulcerative Colitis (Uc)- Treatment Guidelines and Health Technology Assessments (Hta)

    Nov 1, 2015, 00:00

  • Anti-Dementia Medicine Dispensing Patterns- A Community Pharmacy Database Analysis

    Nov 1, 2015, 00:00

  • Identification Of Items For A Standardised Resource-Use Measure- Review Of Current Instruments

    Nov 1, 2015, 00:00

  • A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

    Nov 1, 2015, 00:00

  • The Trends In Orphan Drug Authorisation and Approval In Europe And In The United States - A Retrospective Study (2005-2014)

    Nov 1, 2015, 00:00

  • Relationship Between The Prevalence Of Cancers In England And Wales And The Performance Of Technology Appraisals

    Nov 1, 2015, 00:00

  • A Cost-Effective Enhanced Retrospective Observational Study Methodology to Capture Economic Burden Evidence in a Rare Disease Using Non-Tuberculous Mycobacteria Infection as a Model

    Nov 1, 2015, 00:00

  • Assocations Between Pain Severity and Quality of Life Domains Among Those Diagnosed With Various Pain Types In Europe

    Nov 1, 2015, 00:00

  • How to Determine The Target Population In Early Benefit Assessments In Germany? The Case of Diabetes Mellitus Type 2

    Nov 1, 2015, 00:00

  • Patterns Of Medication Use In Chronic Kidney Disease Stage 5d- Emphasis On Medications For The Management Of Ckd-Mbd

    Nov 1, 2015, 00:00

  • Bone Pain And Bone Targeting Agent (Bta) Treatment Patterns In Patients With Bone Metastases (Bms) From Breast Cancer (Bc) In Real World Setting In Europe

    Nov 1, 2015, 00:00

  • In Greece, During 2009-2014, Public Pharmaceutical Expenditure Undoubtedly Fell; But On Whose Backs?

    Nov 1, 2015, 00:00

  • Impact of Indiscriminate Use of Pump Infusion Set (Pis) on the Cost of Chemotherapy Treatments- A Cost Minimization Study

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Incidence Of Deep Venous Thrombosis And Pulmonary Embolism In Patients With Hip Or Knee Replacement Surgery And Of Its Impact On The Average Length Of Stay And Hospitalization Cost

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland

    Nov 1, 2015, 00:00

  • Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015

    Nov 1, 2015, 00:00

  • Costo Efectividad De La Hemodiálisis En Los Prestadores De Servicios De Dos Aseguradoras A Través De La Evaluación De Indicadores Mínimos Para El Análisis De Resultados Clínicos De La Terapia Dialítica En Colombia

    Nov 1, 2015, 00:00

  • Therapy Of Depression In Cancer And Non-Cancer Patients In German Neuropsychiatric Practices

    Nov 1, 2015, 00:00

  • Cost Savings By The Use Of Bemiparin In The Treatment Of Patients With Venous Thromboembolism In Spain

    Nov 1, 2015, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis among High-Risk Hematologic Cancer Patients in Brazil

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ceritinib Versus Current Therapies for Chemotherapy-Experienced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients in Mexico

    Nov 1, 2015, 00:00

  • Patient Benefits And Cost Savings Predicted For Mineralocorticoid-Receptor Antagonist Treatment Of Early And Advanced Diabetic Kidney Disease

    Nov 1, 2015, 00:00

  • Drug Pricing Reform in China - An Analysis of Piloted Pricing Approaches in the Context of International Experience

    Nov 1, 2015, 00:00

  • Improved Survival With Ipilimumab In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00

  • Clinical Characteristics and Patterns of Care Among Patients With Genotype 1 (G1) Hepatitis C Virus In Europe (Eu)

    Nov 1, 2015, 00:00

  • Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis- A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm)

    Nov 1, 2015, 00:00

  • The Association between Disease Activity and Quality of Life among Patients with Ankylosing Spondylitis in Polish Population

    Nov 1, 2015, 00:00

  • Revision Sistemática De Estudios De Costo Efectividad De Intervenciones Sanitarias Para La Cesacion Del Hábito Tabáquico

    Nov 1, 2015, 00:00

  • The Economic Value Proposition of Hand-Sewn Suture Versus Stapled Anastomoses During Right Colon Surgery

    Nov 1, 2015, 00:00

  • A Pragmatic Approach to Data Source Selection for use In Real-World Evidence (Rwe) Generation

    Nov 1, 2015, 00:00

  • The Rise of Orphan Drugs In Europe Vs The United States- Comparing Orphan Drug Designations Between The Ema And Fda

    Nov 1, 2015, 00:00

  • Trends in Non-Submissions in the UK

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Afatinib As 1st-Line Treatment Of Metastatic Non-Small Cell Lung Cancer With Del19 Mutation Of Egfr Gene

    Nov 1, 2015, 00:00

  • Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85 (current)
  • 86
  • 87
  • 88
  • 89
  • 90
  • »